Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.
A systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.
Austin Chiang, MD, MPH: One innovation that's happening in my specialty of gastroenterology is artificial intelligence. Ben ...
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a reduced risk of COPD exacerbations in patients with type 2 ...